BlackRock Inc. - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 62 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$209,563
-69.5%
1,197,501
-24.6%
0.00%
Q3 2022$688,000
-43.3%
1,587,927
+11.3%
0.00%
Q2 2022$1,213,000
-93.7%
1,426,232
-59.3%
0.00%
-100.0%
Q1 2022$19,318,000
-42.7%
3,506,569
+0.7%
0.00%0.0%
Q4 2021$33,705,000
-45.9%
3,481,801
-0.1%
0.00%
-50.0%
Q3 2021$62,302,000
-25.7%
3,484,480
+1.4%
0.00%0.0%
Q2 2021$83,869,000
-13.0%
3,435,835
-5.5%
0.00%
-33.3%
Q1 2021$96,397,000
+291.2%
3,637,617
+12.0%
0.00%
+200.0%
Q4 2020$24,643,000
+49.6%
3,246,723
-1.2%
0.00%0.0%
Q3 2020$16,470,000
-17.6%
3,287,427
-1.6%
0.00%0.0%
Q2 2020$19,985,000
+48.8%
3,342,144
+10.7%
0.00%0.0%
Q1 2020$13,431,000
-54.5%
3,017,990
-2.8%
0.00%0.0%
Q4 2019$29,494,000
+18.2%
3,104,641
-2.3%
0.00%0.0%
Q3 2019$24,950,000
-43.2%
3,178,092
+13.7%
0.00%
-50.0%
Q2 2019$43,961,000
-8.8%
2,794,691
+4.9%
0.00%0.0%
Q1 2019$48,218,000
+23.4%
2,664,050
+9.6%
0.00%0.0%
Q4 2018$39,083,000
+2.4%
2,430,505
+52.9%
0.00%0.0%
Q3 2018$38,155,0001,589,7980.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders